Structure-based receptor MIMICS targeted against bacterial superantigen toxins
Patent
·
OSTI ID:968328
- Santa Fe, NM
- Los Alamos, NM
- Albuquerque, NM
The invention provides therapeutic compositions useful in the treatment of bacterial superantigen mediated conditions, such as Toxic Shock Syndrome. The compositions comprise genetically engineered bifunctional polypeptides containing a specific T-cell receptor binding domain and a specific MHC class II receptor binding domain, each targeting non-overlapping epitopes on a superantigen molecule against which they are designed. The anti-superantigen "receptor mimetics" or "chimeras" are rationally designed to recreate the modality of superantigen binding directly to both the TCR and the MHC-II receptor, and are capable of acting as decoys for superantigen binding, effectively out-competing the host T-cell and MHC-II receptors, the natural host receptors.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM
- Sponsoring Organization:
- United States Department of Energy
- DOE Contract Number:
- W-7405-ENG-36
- Assignee:
- Los Alamos National Security, LLC (Los Alamos, NM)
- Patent Number(s):
- 7,576,183
- Application Number:
- 10/746,959
- OSTI ID:
- 968328
- Country of Publication:
- United States
- Language:
- English
Similar Records
Therapeutic approaches to superantigen-based diseases: a review
A Novel Loop Domain in Superantigens Extends Their T Cell Receptor Recognition Site
Crystal Structure of a Complete Ternary Complex of TCR, Superantigen and Peptide-MHC
Journal Article
·
Tue Dec 31 23:00:00 EST 2002
· JMR. Journal of Molecular Recognition
·
OSTI ID:811068
A Novel Loop Domain in Superantigens Extends Their T Cell Receptor Recognition Site
Journal Article
·
Sun Dec 31 23:00:00 EST 2006
· Journal of Molecular Biology
·
OSTI ID:929985
Crystal Structure of a Complete Ternary Complex of TCR, Superantigen and Peptide-MHC
Journal Article
·
Sun Dec 31 23:00:00 EST 2006
· Nature Structural and Molecular Biology
·
OSTI ID:930634